Brooklyn ImmunoTherapeutics
BTX
$0.75
Share price
-0.61%
Change (1 day)
N/A
Change (1 year)
Categories
Market capitalization of Brooklyn ImmunoTherapeutics (BTX)
Market cap: $0.04 Billion
As of May 2022 Brooklyn ImmunoTherapeutics has a market cap of $0.04 Billion. This makes Brooklyn ImmunoTherapeutics the world's 6034th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Market cap history of Brooklyn ImmunoTherapeutics from 2021 to 2022
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.04 B | -77.77% |
| 2021 | $0.21 B |
End of Day market cap according to different sources
On May 19th, 2022 the market cap of Brooklyn ImmunoTherapeutics was reported to be:
$0.04 Billion
$0.04 Billion
$0.03 Billion
$0.04 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $133.79 B | 312,289.60% | 🇫🇷 France |
 Baxter BAX | $36.55 B | 85,251.09% | 🇺🇸 USA |
 Geron GERN | $0.49 B | 1,063.26% | 🇺🇸 USA |
 Genetic Technologies GENE | $0.02 B | -52.93% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | $9.30 B | 21,627.26% | 🇮🇱 Israel |
 Bio-Techne TECH | $14.37 B | 33,466.64% | 🇺🇸 USA |